Literature DB >> 16293840

Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.

Ilkka Kalliala1, Ahti Anttila, Eero Pukkala, Pekka Nieminen.   

Abstract

OBJECTIVE: To study the long term risk of cervical and other cancers after treatment for cervical intraepithelial neoplasia.
DESIGN: Retrospective cohort study.
SETTING: University Hospital, Helsinki, Finland. PARTICIPANTS: 7564 women treated for cervical intraepithelial neoplasia during 1974 and 2001 and followed up through the Finnish cancer registry until 2003. MAIN OUTCOME MEASURES: Standardised incidence ratio for cervical cancer and other cancers.
RESULTS: During follow-up 22 cases of invasive cervical cancer occurred in women treated for cervical intraepithelial neoplasia (standardised incidence ratio 2.8, 95% confidence interval 1.7 to 4.2). The highest risk was during the second decade (10 cases observed: 3.1, 1.5 to 5.7). The standardised incidence ratio for cervical intraepithelial cancer type 1 was 3.1 (1.4 to 6.2) and for type 2 was 3.7 (0.9 to 10.7).
CONCLUSIONS: The risk of cervical cancer in the first 20 years after treatment for cervical intraepithelial neoplasia is higher than in the average population. The risk of smoking related cancers is also increased.

Entities:  

Mesh:

Year:  2005        PMID: 16293840      PMCID: PMC1285099          DOI: 10.1136/bmj.38663.459039.7C

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

Review 1.  Surgery for cervical intraepithelial neoplasia.

Authors:  P L Martin-Hirsch; E Paraskevaidis; H Kitchener
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  Interval cervical cancer following treatment for cervical intraepithelial neoplasia.

Authors:  R J. Gornall; I E. Boyd; T. Manolitsas; A. Herbert
Journal:  Int J Gynecol Cancer       Date:  2000-05       Impact factor: 3.437

3.  Screening histories of incidence cases of cervical cancer and high grade SIL. A comparison.

Authors:  J J Baldauf; M Dreyfus; J Ritter; P Meyer; E Philippe
Journal:  Acta Cytol       Date:  1997 Sep-Oct       Impact factor: 2.319

4.  Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.

Authors:  W P Soutter; A de Barros Lopes; A Fletcher; J M Monaghan; I D Duncan; E Paraskevaidis; H C Kitchener
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

5.  The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.

Authors:  A Andersson-Ellström; T Seidal; M Grannas; B Hagmar
Journal:  Acta Obstet Gynecol Scand       Date:  2000-03       Impact factor: 3.636

6.  Effect of a mass screening program on the risk of cervical cancer.

Authors:  M Hakama; U Räsänen-Virtanen
Journal:  Am J Epidemiol       Date:  1976-05       Impact factor: 4.897

7.  Data quality and quality control of a population-based cancer registry. Experience in Finland.

Authors:  L Teppo; E Pukkala; M Lehtonen
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

8.  Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.

Authors:  P D Sasieni; J Cuzick; E Lynch-Farmery
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  8 in total
  28 in total

1.  Cervical intraepithelial neoplasia and higher long term risk of cancer.

Authors:  Guglielmo Ronco; Mario Giovanni Sideri; Stefano Ciatto
Journal:  BMJ       Date:  2007-10-24

2.  Chlamydia trachomatis inclusions induce asymmetric cleavage furrow formation and ingression failure in host cells.

Authors:  He Song Sun; Andrew Wilde; Rene E Harrison
Journal:  Mol Cell Biol       Date:  2011-10-03       Impact factor: 4.272

3.  Epidemiology of vulvar neoplasia in the NIH-AARP Study.

Authors:  Louise A Brinton; Jake E Thistle; Linda M Liao; Britton Trabert
Journal:  Gynecol Oncol       Date:  2017-02-22       Impact factor: 5.482

4.  Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.

Authors:  Björn Strander; Agneta Andersson-Ellström; Ian Milsom; Pär Sparén
Journal:  BMJ       Date:  2007-10-24

5.  Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study.

Authors:  Joy Melnikow; Colleen McGahan; George F Sawaya; Thomas Ehlen; Andrew Coldman
Journal:  J Natl Cancer Inst       Date:  2009-05-12       Impact factor: 13.506

6.  Treatment strategies in intermediate cervical neoplasia: Implications of radical surgery.

Authors:  K W M VAN Delft; H J M M Mertens
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

7.  Association Between Positive Human Papillomavirus Status After Conization and Disease Recurrence in Patients with Cervical Intraepithelial Neoplasia Grade 3.

Authors:  Masaki Kamio; Shintaro Yanazume; Shinichi Togami; Hiroaki Kobayashi
Journal:  J Obstet Gynaecol India       Date:  2020-09-10

8.  Breast cancer and ductal carcinoma in situ among women with prior squamous or glandular precancer in the cervix: a register-based study.

Authors:  B T Hansen; M Nygård; R S Falk; S Hofvind
Journal:  Br J Cancer       Date:  2012-09-25       Impact factor: 7.640

9.  Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females.

Authors:  Diane M Harper; Stephen L Vierthaler
Journal:  ISRN Obstet Gynecol       Date:  2011-11-02

10.  Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.

Authors:  Matejka Rebolj; Theo Helmerhorst; Dik Habbema; Caspar Looman; Rob Boer; Joost van Rosmalen; Marjolein van Ballegooijen
Journal:  BMJ       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.